Trials / Recruiting
RecruitingNCT05166694
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
Evaluating the Effectiveness of a Personalized Therapeutics Clinic (PTC) Intervention on Drug-Drug Interactions (DDIs) and Drug-Gene Interactions (DGIs)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,300 (estimated)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether a consultation with a Personalized Therapeutics Clinic, or PTC, will help participants lower the risk for side effects (drug-drug interactions and drug-gene interactions) when taking many medications and help providers improve prescribing decisions for participants. A PTC is a clinical that will test your genes to gather information about your health that may help guide prescribing advice and offer you new information about your prescriptions. Doctors leading this study will look for variations (differences) in your genes that may suggest that you are at greater risk of having side effects or a greater chance of benefiting from certain medications. Individuals in this study will participate for roughly 9 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Drug-Drug Interaction Profile | A profile based on genetic testing that shows information about how the participant's medications they are taking interact with each other. |
| OTHER | Drug-Gene Interaction Profile | A profile based on genetic testing that shows information about how the participant's genes interact with/respond to certain medications they are taking. |
| OTHER | Standard of Care | The standard treatment and prescribing for the participant's specific type of cancer. |
Timeline
- Start date
- 2022-11-30
- Primary completion
- 2027-11-01
- Completion
- 2027-11-01
- First posted
- 2021-12-22
- Last updated
- 2026-03-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05166694. Inclusion in this directory is not an endorsement.